ENTITY

Respiri Ltd (RSH AU)

25
Analysis
Health CareAustralia
Respiri Limited develops and commercializes medical devices. The Company offers wheeze detection devices, inhalers, acoustic sensors, and electronic asthma diaries. as well as renders smartphone applications to detect and measure wheezing and coughing problems. Respiri serves customers worldwide.
more
bullishRespiri Ltd
07 Jun 2023 23:12Issuer-paid

Respiri - Investor recap of Respiri’s strategic focus

Respiri’s recent investor presentation recapped management’s strategic rationale for and the merits of the company’s proposed acquisition of Access...

Share
bullishRespiri Ltd
23 May 2023 18:04Issuer-paid

Respiri - Telehealth acquisition to bolster US roll-out

In a strategic push of its US commercialisation strategy, Respiri has announced the proposed acquisition of Access Managed Services, its US remote...

Share
bullishRespiri Ltd
28 Apr 2023 16:26Issuer-paid

Respiri - Commercialisation at the forefront

Respiri released its Q323 activity report, updating investors on key highlights during the quarter. The period was marked by continued expansion of...

Share
bullishRespiri Ltd
29 Mar 2023 15:20Issuer-paid

Respiri - Wheezo commercialization picking up pace

In a recent business update, Respiri recapped its commercialisation efforts for the wheezo device and associated remote patient monitoring (RPM)...

Share
bullishRespiri Ltd
01 Mar 2023 15:28Issuer-paid

Respiri - Strong momentum heading into FY24

Respiri’s H123 report summarised an eventful period, marked by commercial traction (six client wins; patient onboarding commenced at four centres)...

Share
x